Chemoinformaics analysis of 2-alkyl-3-methoxypyrazines
Molecular Weight | 138.17 | nRot | 2 |
Heavy Atom Molecular Weight | 128.09 | nRig | 6 |
Exact Molecular Weight | 138.079 | nRing | 1 |
Solubility: LogS | -0.555 | nHRing | 1 |
Solubility: LogP | 1.556 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 21.3599 |
nHD | 0 | BPOL | 14.0481 |
QED | 0.612 |
Synth | 2.401 |
Natural Product Likeliness | -0.904 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.317 |
MDCK | 0.000037 |
BBB | 0.741 |
PPB | 0.329381 |
VDSS | 1.328 |
FU | 0.578321 |
CYP1A2-inh | 0.387 |
CYP1A2-sub | 0.707 |
CYP2c19-inh | 0.069 |
CYP2c19-sub | 0.859 |
CYP2c9-inh | 0.009 |
CYP2c9-sub | 0.583 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.678 |
CYP3a4-inh | 0.017 |
CYP3a4-sub | 0.278 |
CL | 8.09 |
T12 | 0.649 |
hERG | 0.017 |
Ames | 0.097 |
ROA | 0.295 |
SkinSen | 0.888 |
Carcinogencity | 0.354 |
EI | 0.949 |
Respiratory | 0.898 |
NR-Aromatase | 0.026 |
Antiviral | No |
Prediction | 0.905072 |